Sleep and signs of attention during 3 months of intranasal vasopressin: A pilot study in two elderly subjects

Peptides

Volumn 17, Issue 7, 1996, Pages 1253-1255

  Perras, Boris ^a   Mölle, Matthias ^a   Born, Jan ^a   Fehm, Horst L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

cortisol; event related brain potentials; P3; rapid eye movement sleep; slow wave sleep

Indexed keywords

ARGIPRESSIN; VASOPRESSIN;

AGED; ARTICLE; ATTENTION; CASE REPORT; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EVOKED RESPONSE; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REM SLEEP; SLOW WAVE SLEEP;

ADMINISTRATION, INTRANASAL; AGED; AGED, 80 AND OVER; AGING; ATTENTION; FEMALE; HUMANS; MALE; PILOT PROJECTS; SLEEP; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 0029909879     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(96)00173-8     Document Type: Article

References (11)

1. 1. Born, J.; De Kloet, E. R.; Wenz, H.; Kern, W.; Fehm, H. L. Glucoand antimineralocorticoid effects on human sleep: A role of central corticosteroid receptors. Am. J. Physiol. Endocrinol. Metab. 260(23):E183-188; 1991.
2. 2. Born, J.; Kellner, C.; Uthgenannt, D.; Kern, W.; Fehm, H. L. Vasopressin regulates human sleep by reducing rapid-eye-movement sleep. Am. J. Physiol. Endocrinol. Metab. 262(25):E295-300; 1992.
3. 3. Dodt, C.; Pietrowsky, R.; Sewing, A.; Zabel, A.; Fehm, H. L.; Born, J. Effects of vasopressin on event-related potential indicators of cognitive stimulus processing in young and old humans. J. Gerontol. 49:M183-188; 1994.
4. 4. Fehm-Wolfsdorf, G.; Born, J. Behavioral effects of neurohypophyseal peptides in healthy volunteers: 10 years of research. Peptides 12:1399-1406; 1991.
5. 5. Janke, W.; Debus, G. Die Eigenschaftswörterliste EWL. Eine mehrdimensionale Methode zur Beschreibung von Aspekten des Befindens. Göttingen: Hogrefe; 1978.
6. 6. Kazdin, A. E. Statistical analyses for single-case experimental designs. In: Hersen, M.; Barlow, D. M., eds. Single-case experimental designs: Strategies for studying behavior change. New York: Pergamon Press; 1976:265-313.
7. 7. Rechtschaffen, A.; Kales, A. A manual of standardized terminology, techniques and scoring system for sleep of human subjects. NIH publ. No. 204. Washington, DC: US Govt. Printing Office; 1968.
8. 8. Swaab, D. F.; Fliers, E.; Partiman, T. S. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. 342:37-44; 1985.
9. 9. Timsit-Berthier, M.; Mantanus, H.; Devos, J. E.; Spiegel, R. Action of lysin vasopressin on human electroencephalographic activity. Neuropsychobiology 8:248-258; 1982.
10. 10. Van Ree, J. M.; Hijman, R.; Jolles, J.; De Wied, D. Vasopressin and related peptides: Animal and human studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 9:551-559; 1985.
11. 11. Veldhuis, D.; De Kloet, E. R. Vasopressin-related peptides increase the hippocampal corticosterone receptor capacity of diabetes insipidus (Brattleboro) rats. Endocrinology 110:153-157; 1982.